HuGE Literature Finder
|
||
Records 1-5
|
The influence of genetic variability of DNA repair mechanisms on the risk of malignant mesothelioma.
Radiology and oncology 2019 Mar . Levpuscek Kristina, Goricar Katja, Kovac Viljem, Dolzan Vita, Franko Alen |
|
Clinical-pharmacogenetic models for personalized cancer treatment: application to malignant mesothelioma.
Scientific reports 2017 Apr 7 46537. Gori?ar Katja, Kova? Viljem, Dolžan Vi |
|
DNA repair polymorphisms and treatment outcomes of patients with malignant mesothelioma treated with gemcitabine-platinum combination chemotherapy.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012 Oct 7 (10): 1609-17. Er?ulj Nina, Kova? Viljem, Hmeljak Julija, Franko Alenka, Dodi?-Fikfak Metoda, Dolžan Vi |
|
XRCC1 and ERCC1 variants modify malignant mesothelioma risk: a case-control study.
Mutation research 2011 Mar 708 (1-2): 11-20. Betti M, Ferrante D, Padoan M, Guarrera S, Giordano M, Aspesi A, Mirabelli D, Casadio C, Ardissone F, Ruffini E, Betta P G, Libener R, Guaschino R, Matullo G, Piccolini E, Magnani C, Dianzani |
|
Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study.
Mutation research 2006 Jul 599 (1-2): 124-34. Dianzani I, Gibello L, Biava A, Giordano M, Bertolotti M, Betti M, Ferrante D, Guarrera S, Betta G P, Mirabelli D, Matullo G, Magnani |
- Page last reviewed:Jul 30, 2019
- Page last updated:Oct 31, 2019
- Content source: